These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1483591

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease.
    Molica S, Alberti A.
    Haematologica; 1990; 75(1):75-8. PubMed ID: 2338291
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
    Zinzani PL, Levrero MG, Lauria F, Rondelli D, Zaja F, Russo D, Fanin R, De Rossi G, Mauro FR, Bendandi M, Gozzetti A, Dianzani F, Mandelli F, Tura S.
    Haematologica; 1994; 79(1):55-60. PubMed ID: 15378949
    [Abstract] [Full Text] [Related]

  • 5. Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
    Mauro FR, Zinzani P, Zaja F, Gentile M, Vegna ML, Stefoni V, Marin L, Fanin R, Baccarani M, Tura S, Mandelli F.
    Haematologica; 2003 Dec; 88(12):1348-57. PubMed ID: 14687987
    [Abstract] [Full Text] [Related]

  • 6. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F.
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up.
    Boussiotis VA, Pangalis GA.
    Br J Haematol; 1991 Oct; 79 Suppl 1():30-3. PubMed ID: 1931705
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C, Elewaut A, Philippé J, Elewaut AE, Desombere I, Maertens G, Leroux-Roels G.
    Rev Invest Clin; 2002 Oct; 54(1):41-50. PubMed ID: 11995406
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases].
    Nese M, de Bellis R, Urtiarte R, Di Landro J.
    Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047
    [Abstract] [Full Text] [Related]

  • 13. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S, De Rossi G, Luciani M, Levato D.
    Haematologica; 1995 Jun; 80(2):176-93. PubMed ID: 7628755
    [Abstract] [Full Text] [Related]

  • 14. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
    Zielińska W, Korczak-Rogoń A, Paszkiewicz J, Kowalik M, Cummins JM, Georgiades JA.
    Arch Immunol Ther Exp (Warsz); 1996 Oct; 44(5-6):359-66. PubMed ID: 9017152
    [Abstract] [Full Text] [Related]

  • 16. Effects of alpha-interferon and steroids on CD23 expression and release in B-cell chronic lymphocytic leukemia.
    Pozzato G, de Paoli P, Franzin F, Tulissi P, Moretti M, Basaglia G, Santini GF.
    Haematologica; 1994 Oct; 79(3):205-12. PubMed ID: 7926968
    [Abstract] [Full Text] [Related]

  • 17. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P, Zelen I, Ristic P, Baskic D, Popovic S, Arsenijevic N.
    Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy.
    Jewell AP, Worman CP, Giles FJ, Goldstone AH.
    Leuk Lymphoma; 1997 Jan; 24(3-4):327-33. PubMed ID: 9156662
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.